Zheng Hu Selected Research

Complement Factor I (C3b Inactivator)

10/2022	Functional analysis of rare genetic variants in complement factor I in advanced age-related macular degeneration.
1/2022	Post-Transplant Thrombotic Microangiopathy due to a Pathogenic Mutation in Complement Factor I in a Patient With Membranous Nephropathy: Case Report and Review of Literature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zheng Hu Research Topics

Disease

67	Neoplasms (Cancer) 01/2022 - 10/2007
17	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2021 - 05/2014
17	Carcinogenesis 05/2021 - 03/2011
8	Carcinoma (Carcinomatosis) 01/2022 - 01/2016
8	Leukemia 11/2021 - 08/2009
8	Human Influenza (Influenza) 06/2021 - 03/2013
7	Neoplasm Metastasis (Metastasis) 08/2021 - 08/2015
6	Breast Neoplasms (Breast Cancer) 08/2021 - 10/2009
6	Glioma (Gliomas) 10/2020 - 03/2014
5	Fibrosis (Cirrhosis) 01/2022 - 01/2016
5	Infections 01/2022 - 08/2006
5	Papillomavirus Infections 10/2020 - 01/2015
5	Melanoma (Melanoma, Malignant) 01/2020 - 09/2014
4	Rolandic Epilepsy (Centrotemporal Epilepsy) 02/2022 - 05/2017
4	Inflammation (Inflammations) 01/2022 - 10/2017
4	Necrosis 01/2022 - 06/2009
3	Chronic Renal Insufficiency 01/2022 - 01/2019
3	Genomic Instability 05/2021 - 02/2014
3	Acute Kidney Injury (Acute Renal Failure) 05/2021 - 01/2017
3	Lung Neoplasms (Lung Cancer) 12/2020 - 01/2011
3	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 08/2012
3	Asthma (Bronchial Asthma) 01/2019 - 05/2014
3	Absence Epilepsy (Childhood Absence Epilepsy) 01/2019 - 03/2014
3	Pain (Aches) 12/2018 - 03/2006
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2017 - 02/2011
2	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2022 - 05/2017
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2015
2	Colorectal Neoplasms (Colorectal Cancer) 11/2021 - 01/2019
2	Hypoxia (Hypoxemia) 10/2021 - 01/2021
2	Nasopharyngeal Carcinoma 01/2021 - 01/2016
2	Hyperplasia 01/2021 - 05/2004
2	Retinoblastoma (Glioblastoma, Retinal) 10/2020 - 01/2015
2	Lymphopenia (Lymphocytopenia) 10/2020 - 08/2016
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 06/2016
2	Stroke (Strokes) 01/2019 - 10/2016
2	Squamous Cell Carcinoma of Head and Neck 01/2019 - 01/2018
2	Hyperhomocysteinemia 01/2019 - 01/2017
2	Uterine Cervical Dysplasia 01/2018 - 05/2014
2	Lymphatic Metastasis 01/2018 - 10/2014
2	Malocclusion (Crossbite) 04/2017 - 10/2015
2	Genetic Translocation (Chromosomal Translocation) 08/2016 - 04/2014
2	Postpartum Depression (Post-Natal Depression) 06/2015 - 09/2013
2	HIV Infections (HIV Infection) 02/2008 - 08/2006
2	Acquired Immunodeficiency Syndrome (AIDS) 02/2008 - 08/2006

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2007
15	Pharmaceutical PreparationsIBA 02/2022 - 01/2011
13	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2008
8	Biological ProductsIBA 08/2021 - 03/2006
7	DNA (Deoxyribonucleic Acid)IBA 05/2021 - 03/2013
6	Messenger RNA (mRNA)IBA 10/2020 - 03/2014
5	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2010
5	VaccinesIBA 06/2021 - 05/2015
5	AcidsIBA 01/2020 - 09/2014
5	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 04/2014
5	Small Interfering RNA (siRNA)IBA 01/2019 - 01/2011
4	Oncogene Proteins (Oncogene Protein)IBA 01/2020 - 01/2011
4	Caspase 3 (Caspase-3)IBA 01/2019 - 01/2015
4	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2018 - 03/2013
4	MicroRNAs (MicroRNA)IBA 10/2018 - 08/2012
3	AntibodiesIBA 01/2022 - 07/2010
3	CytokinesIBA 01/2022 - 11/2016
3	Indicators and Reagents (Reagents)IBA 08/2021 - 01/2016
3	Aldo-Keto Reductase Family 1 member B10IBA 08/2021 - 01/2016
3	Levetiracetam (Keppra)FDA LinkGeneric 01/2020 - 05/2017
3	ChromatinIBA 01/2020 - 01/2017
3	AntigensIBA 10/2017 - 09/2015
3	insulin receptor-related receptor (IRR)IBA 01/2017 - 05/2014
2	Complement Factor I (C3b Inactivator)IBA 10/2022 - 01/2022
2	Monoclonal AntibodiesIBA 01/2022 - 10/2007
2	trimethyloxamine (trimethylamine N-oxide)IBA 01/2022 - 01/2022
2	plerixafor FDA Link 11/2021 - 01/2018
2	SurvivinIBA 08/2021 - 01/2020
2	Aldo-Keto ReductasesIBA 01/2021 - 01/2016
2	EstersIBA 10/2020 - 10/2018
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2020 - 01/2018
2	CateninsIBA 01/2020 - 01/2016
2	OligodeoxyribonucleotidesIBA 01/2020 - 01/2018
2	Histones (Histone)IBA 01/2020 - 04/2014
2	Vascular Endothelial Growth Factor CIBA 04/2019 - 10/2014
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2019 - 05/2017
2	Viral DNAIBA 10/2018 - 01/2015
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 01/2016
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018 - 05/2017
2	Transcription Activator-Like Effector NucleasesIBA 12/2015 - 01/2015
2	Tuberculin (PPD)IBA 06/2015 - 09/2013
2	Phosphopyruvate Hydratase (Enolase)IBA 01/2015 - 03/2014
2	EnzymesIBA 03/2014 - 03/2011
2	rabdocoetsin BIBA 01/2011 - 08/2009
2	Genetic Markers (Genetic Marker)IBA 04/2010 - 04/2010
2	Proteasome InhibitorsIBA 08/2009 - 07/2009
1	chemotactic factor inactivatorIBA 10/2022

Therapy/Procedure

33	Therapeutics 03/2022 - 01/2004
6	Transplantation 01/2018 - 08/2015
5	Drug Therapy (Chemotherapy) 01/2020 - 08/2015
4	Immunotherapy 01/2020 - 02/2016
4	Precision Medicine 10/2018 - 04/2017
2	Hematopoietic Stem Cell Transplantation 03/2022 - 01/2017
2	Radiotherapy 01/2021 - 04/2018
2	Anesthesia 01/2019 - 05/2017
2	Highly Active Antiretroviral Therapy (HAART) 08/2006 - 03/2006